A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy Volunteers
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- OphRx Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT05184517
- Locations
- 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath